Fundación Epic
Clinical trials sponsored by Fundación Epic, explained in plain language.
-
New heart stent under Real-World watch
Disease control OngoingThis study is a registry that follows 400 people with coronary artery disease who received the ihtDEStiny drug-eluting stent during a routine procedure to open blocked heart arteries. Researchers are tracking how well the stent works over time, including rates of death, heart att…
Sponsor: Fundación EPIC • Aim: Disease control
Last updated May 26, 2026 04:30 UTC
-
New stent shows promise for faster heart vessel healing
Disease control OngoingThis study tests two different stents (tiny mesh tubes) used to open blocked heart arteries. It compares a newer drug-coated stent without a permanent polymer to a standard one, to see which allows the artery lining to heal faster after placement. About 40 adults with coronary ar…
Phase: NA • Sponsor: Fundación EPIC • Aim: Disease control
Last updated May 22, 2026 14:02 UTC
-
Blood test could slash bleeding risks for heart attack survivors
Disease control OngoingThis study tests whether a blood test can help doctors safely lower the dose of strong blood thinners (P2Y12 inhibitors) in people who have had a heart attack or unstable chest pain and received a stent. The goal is to reduce bleeding complications without increasing the risk of …
Phase: PHASE4 • Sponsor: Fundación EPIC • Aim: Disease control
Last updated May 22, 2026 13:54 UTC
-
New study aims to sharpen diagnosis of heart artery narrowing
Diagnosis OngoingThis study compares two imaging techniques, OCT and IVUS, to better evaluate blockages in the left main coronary artery. Researchers will enroll 153 adults with intermediate blockages to see which method provides clearer guidance for treatment. The goal is to improve accuracy and…
Sponsor: Fundación EPIC • Aim: Diagnosis
Last updated May 26, 2026 03:55 UTC
-
Heart valve patients may go home in just 24 hours!
Symptom relief OngoingThis study looks at whether it is safe for people with narrowed heart valves to leave the hospital just 24 hours after a minimally invasive valve replacement (TAVI). Researchers will track 585 patients for serious problems like stroke, heart attack, or need for a pacemaker. The g…
Sponsor: Fundación EPIC • Aim: Symptom relief
Last updated May 26, 2026 03:57 UTC
-
Spanish heart study reveals Real-World blood thinner use
Knowledge-focused OngoingThis study looks at how doctors in Spain use blood-thinning drugs during heart procedures called PCI (stent placement). Researchers will track 717 patients to see which drugs are used and how well they work in everyday practice. The goal is to understand short-term safety and eff…
Sponsor: Fundación EPIC • Aim: Knowledge-focused
Last updated May 14, 2026 12:03 UTC